Immuneel Therapeutics Pvt. Ltd.
Accelerating access to Cell & Gene Therapies
Accelerating access to Cell & Gene Therapies
Immuneel Therapeutics Pvt. Ltd. is a pioneering clinical stage startup company founded in 2018 with a vision to revolutionize the Health Care industry by accelerating access to Cell & Gene Therapies. The company's slogan "Accelerating access to Cell & Gene Therapies" reflects their dedication to bringing breakthrough cancer treatment to patients in India and making it accessible & affordable. In June 2022, the company secured a significant $15.00M Series A investment from prominent investors including Eight Roads Ventures, F-Prime Capital, and True North. This funding not only validates the company's potential but also provides the financial support necessary to advance their mission of transforming cancer treatment in India. Immuneel Therapeutics' innovative approach and strong investor backing position them as a promising player in the evolving landscape of cell and gene therapies, with the potential to make a meaningful impact on cancer patients' lives in India and beyond.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | INR1.00B | 1 | Taiba Healthcare | 10 Jul 2024 |
| Series A | $15.00M | 3 |
|
21 Jun 2022 |
| Seed Round | Unknown | 2 |
|
01 Jan 2020 |
No recent news or press coverage available for Immuneel Therapeutics Pvt. Ltd..
We care about your data, and we'd love to use cookies make your experience better.